Mark L. Pacala

Mark L. Pacala discloses dealings in 2 companies, chiefly Starling Oncology, Inc. and Patient Infosystems Inc. The record holds 16 filings, for trades running from 27 November 2006 to 27 July 2026.

The open-market side counts 1 purchase for €87k alongside 3 sales for €173k. On balance, insiders were net sellers of €85k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 10 share grants.

The newest entry dates from 29 July 2026: a share grant, in Starling Oncology, Inc. The last purchase on record was published on 28 March 2025, which is 575 days ago. The median gap between a trade and its publication by SEC (Form 4) is 3 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.